サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1678792

糖尿病管理アプリの世界市場（2025年～2033年）

Global Diabetes Management Apps Market - 2025-2033

出版日
ページ情報
英文 192 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
糖尿病管理アプリの世界市場（2025年～2033年）
出版日: 2025年03月11日
発行: DataM Intelligence
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の糖尿病管理アプリの市場規模は、2024年に13億7,000万米ドルに達し、2033年には99億米ドルに達すると予測され、予測期間2025年～2033年にCAGR24.7%で成長する見込みです。

糖尿病管理アプリは、糖尿病患者のモニタリングと管理を支援するために設計されたモバイルアプリケーションです。これらのアプリは、血糖値、投薬、食事、身体活動、全体的な健康状態など、糖尿病に関連する主要な健康指標の追跡と管理を支援するデジタルツールとして機能します。これらのアプリは、糖尿病の治療に関して十分な情報に基づいた意思決定を行い、処方された治療のアドヒアランスを向上させ、最終的には糖尿病に関連する合併症のリスクを低減するために必要なサポートを個人に提供することを目的としています。

市場力学：

促進要因と抑制要因

糖尿病有病率の上昇

糖尿病有病率の上昇は、糖尿病管理アプリ市場の成長を大きく後押ししており、予測期間中も市場を牽引していくとみられます。国際糖尿病連合（IDF）によると、2021年には約5億3,700万人の成人（20～79歳）が糖尿病を患っており、この数は2045年までに7億8,300万人に増加すると予測されています。このような糖尿病患者の増加は、アプリのような糖尿病管理ツールの大規模かつ拡大する市場を生み出します。糖尿病と診断される人が増えれば増えるほど、アクセスしやすく効率的で、個人に合わせた管理ソリューションへの需要が高まります。

糖尿病では、血糖値、投薬、食事、ライフスタイルの継続的なモニタリングと管理が必要です。ヘルスケア提供者への頻繁な訪問を含む従来の方法は、時間とコストがかかります。糖尿病管理アプリは、スマートフォンで日々の状態をモニターできる機能をユーザーに提供することで、このギャップを埋める手助けをし、糖尿病をより効果的に管理し、低血糖、心血管障害、腎臓障害などの合併症のリスクを軽減します。

例えば、mySugrは世界で400万人以上の登録ユーザーを持ち、80カ国以上、24の言語で利用可能で、世界で最も人気のある糖尿病管理アプリの一つです。このアプリは、グルコースメーターやインスリンポンプからのデータを統合し、パーソナライズされたレコメンデーションを提供することで、ユーザーが自分の状態をより効果的に把握できるよう支援しています。

データプライバシーとセキュリティへの懸念

データプライバシーとセキュリティへの懸念は、糖尿病アプリ市場の成長を妨げる重大な要因です。これらのアプリは、個人データ、血糖値、服薬記録、その他の健康指標を含む機密性の高い健康情報を扱うため、データ漏洩、不正アクセス、悪用のリスクが潜在的なユーザー、ヘルスケア提供者、規制当局の間で懸念されています。

例えば、HIPAAジャーナルによると、2023年8月には2,300万件のヘルスケア記録の漏洩が指摘されています。過去12ヶ月間、毎月平均998万9,003件の医療記録が漏洩しています。2024年8月31日までの1年間で、500件以上のデータ漏洩が491件発生し、少なくとも5,866万8,002件が漏洩したことが判明しています。2024年の平均情報漏洩件数は11万9,487件、中央値は4,109件です。

目次

第1章 市場イントロダクションと範囲

  • レポートの目的
  • 調査のカバー範囲と定義
  • 調査の対象範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • スニペット：サブスクリプションモデル別
  • スニペット：サービスタイプ別
  • スニペット：オペレーティングシステム（OS）プラットフォーム別
  • スニペット：用途別
  • スニペット：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 糖尿病の罹患率の上昇
      • 技術の進歩の高まり
    • 抑制要因
      • データプライバシーとセキュリティに関する懸念
      • 規制の監視とコンプライアンス
    • 機会
      • パーソナライズされた糖尿病ケアのためのAIと機械学習
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • テクノロジーと動向分析

第5章 糖尿病管理アプリ市場：サブスクリプションモデル別

  • 無料サブスクリプションモデル
  • 有料サブスクリプションモデル

第6章 糖尿病管理アプリ市場：サービスタイプ別

  • デジタル糖尿病管理
  • 糖尿病患者の体重と食事管理

第7章 糖尿病管理アプリ市場、オペレーティングシステム（OS）プラットフォーム別

  • Android
  • iOS

第8章 糖尿病管理アプリ市場：用途別

  • 在宅糖尿病管理
  • AIベースの予測糖尿病分析

第9章 糖尿病管理アプリ市場：地域別の市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Welldoc, Inc.
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Omada Health Inc.
  • Glooko, Inc.
  • Azumio Inc.
  • Abbott Laboratories
  • mySugr GmbH
  • SquareMed Software GmbH
  • Health2Sync
  • iHealth Labs Inc.
  • SIRMA MEDICAL SYSTEMS AD

第12章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証とバリデーション

第13章 付録

目次
Product Code: HCIT9287

The global diabetes management apps market reached US$ 1.37 billion in 2024 and is expected to reach US$ 9.90 billion by 2033, growing at a CAGR of 24.7% during the forecast period 2025-2033.

Diabetes management apps are mobile applications designed to help individuals with diabetes monitor and manage their condition. These apps serve as digital tools to assist users in tracking and managing key health metrics related to diabetes, such as blood glucose levels, medication, diet, physical activity, and overall health status. These apps aim to provide individuals with the support needed to make informed decisions regarding their diabetes care, improve adherence to prescribed treatments, and ultimately help reduce the risk of diabetes-related complications.

Market Dynamics: Drivers & Restraints

Rising prevalence of diabetes

The rising prevalence of diabetes is significantly driving the growth of the diabetes management apps market and is expected to drive the market over the forecast period. According to the International Diabetes Federation (IDF, approximately 537 million adults (20-79 years old) were living with diabetes in 2021, and this number is expected to increase to 783 million by 2045. This growing number of people with diabetes creates a large and expanding market for diabetes management tools like apps. As more individuals are diagnosed, the demand for accessible, efficient, personalized management solutions rises.

Diabetes requires continuous monitoring and management of blood glucose levels, medication, diet, and lifestyle. Traditional methods, including frequent visits to healthcare providers, can be time-consuming and costly. Diabetes management apps help bridge this gap by offering users the ability to monitor their condition on a day-to-day basis through their smartphones, thus ensuring they can manage their diabetes more effectively and reduce the risk of complications such as hypoglycemia, cardiovascular issues, and kidney problems, among others.

For instance, mySugr, with more than four million registered users globally and availability in over 80 countries and 24 languages, is one of the world's most popular diabetes management apps. The app integrates data from glucose meters and insulin pumps to provide personalized recommendations, helping users track their condition more effectively.

Data privacy and security concerns

Data privacy and security concerns are significant factors hampering the growth of the diabetes apps market. Since these apps handle sensitive health information, including personal data, blood glucose levels, medication records, and other health metrics, the risk of data breaches, unauthorized access, and misuse raises concerns among potential users, healthcare providers, and regulators.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records were noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records, and the median breach size is 4,109 records.

Segment Analysis

The global diabetes management apps market is segmented based on subscription model, type of service, Operating System (OS) platform, application, and region.

Application:

Home-based diabetes management in the application segment is expected to dominate the diabetes management apps market with the highest market share.

Home-based management apps allow individuals to monitor blood glucose levels, track insulin usage, and manage their diet and physical activity without needing to visit healthcare providers regularly. This is particularly beneficial for individuals with busy lifestyles, older adults, or those living in remote areas where access to healthcare is limited. The rise of telemedicine and remote monitoring has further boosted home-based diabetes management. Healthcare providers are now able to remotely monitor patients' health data in real time, leading to more personalized and timely interventions.

For instance, in November 2024, PureHealth revealed a huge surge in users of Pura, the group's AI-enabled app. Pura launched a highly anticipated diabetes care module that simplifies diabetes management by offering real-time glucose tracking and personalized meal plans. Patients can manage their entire healthcare journey, from appointments and follow-ups to home medicine delivery and payment options, including self-pay and insurance integration. In the future, the app will enable users to arrange home sample collections for their routine tests, along with other new tools to enhance the patient journey.

Home-based apps offer personalized insights based on data collected from users, such as blood sugar levels, meals, exercise, and medication. This allows users to make real-time adjustments and helps prevent complications associated with diabetes. For instance, Glooko is a diabetes management app that provides personalized insights by integrating data from glucose meters, wearables, and fitness trackers. This allows users to better understand the impact of their daily activities on their blood sugar levels, enabling more informed decision-making.

Geographical Analysis

North America is expected to hold a significant position in the diabetes management apps market with the highest market share

North America, particularly the United States, has one of the highest rates of diabetes, creating a large market for diabetes management apps. According to the American Diabetes Association (ADA), more than 38 million Americans have diabetes, with an additional 96 million having prediabetes. This high number of individuals with diabetes drives the demand for digital tools to manage the condition.

North American companies are leading the way in terms of technological advancements in diabetes care, integrating artificial intelligence (AI), machine learning, and wearable devices with diabetes apps. These technologies help users better understand their condition and manage it more effectively. For instance, the Dexcom G6 CGM system, a product used in conjunction with diabetes management apps, provides real-time glucose monitoring and integrates with mobile apps for continuous tracking. This system is widely used across North America, with the company being headquartered in the U.S.

Competitive Landscape

The major global players in the diabetes management apps market include Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, SquareMed Software GmbH, Health2Sync, iHealth Labs Inc., and SIRMA MEDICAL SYSTEMS AD, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diabetes management apps market report delivers a detailed analysis with 70 key tables, more than 58 visually impactful figures, and 192 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Subscription Model
  • 2.4. Snippet by Type of Service
  • 2.5. Snippet by Operating System (OS) Platform
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Diabetes
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Data Privacy and Security Concerns
      • 3.1.2.2. Regulatory Scrutiny and Compliance
    • 3.1.3. Opportunity
      • 3.1.3.1. AI and Machine Learning for Personalized Diabetes Care
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Technology and Trend Analysis

5. Diabetes Management Apps Market, By Subscription Model

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 5.1.2. Market Attractiveness Index, By Subscription Model
  • 5.2. Free Subscription Model*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Paid Subscription Model

6. Diabetes Management Apps Market, By Type of Service

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 6.1.2. Market Attractiveness Index, By Type of Service
  • 6.2. Digital Diabetes Management*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Diabetic Weight & Diet Management

7. Diabetes Management Apps Market, By Operating System (OS) Platform

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 7.1.2. Market Attractiveness Index, By Operating System (OS) Platform
  • 7.2. Android*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. iOS

8. Diabetes Management Apps Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Home-Based Diabetes Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. AI-Based Predictive Diabetes Analytics

9. Diabetes Management Apps Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Subscription Model
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Service
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operating System (OS) Platform
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Welldoc, Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Omada Health Inc.
  • 11.3. Glooko, Inc.
  • 11.4. Azumio Inc.
  • 11.5. Abbott Laboratories
  • 11.6. mySugr GmbH
  • 11.7. SquareMed Software GmbH
  • 11.8. Health2Sync
  • 11.9. iHealth Labs Inc.
  • 11.10. SIRMA MEDICAL SYSTEMS AD

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us